Takeda تقدم بيانات طويلة الأمد من المرحلة الثالثة من التجربة السريرية ADVANCE-CIDP 3 الخاصة بشركة HYQVIA® على المرضى الذين يعانون من الاعتلال العصبي المتعدد الالتهابي المزمن المزيل للنخاعين (CIDP) في الاجتماع السنوي لـ PNS Haz 20, 2024 System Admin Healthcare
Eid visit to alternates at water & sanitation operational sites in Hodeida Haz 20, 2024 Beatriz Escanilla Healthcare
Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting Haz 18, 2024 System Admin Healthcare
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome Haz 17, 2024 System Admin Healthcare
Janzour waste collection and composting stations inaugurated – with help of the EU, German Embassy and GIZ Haz 15, 2024 Beatriz Escanilla Healthcare
Health minister enhances medical preparations for high temperatures during Eid Al-Adha Haz 15, 2024 Beatriz Escanilla Healthcare
Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI) Haz 14, 2024 System Admin Healthcare
